Effectively Selecting a Target Population for a Future Comparative Study

REFERENCES

• Akaike , H. 1973 . “Information Theory and an Extension of the Maximum Likelihood Principle,” . In Second International Symposium on Information Theory (vol. 1) , 267 – 281 . Berlin : Springer Verlag .
   Google Scholar
• Andersen , P. , Hansen , M. and Klein , J. 2004 . “Regression Analysis of Restricted Mean Survival Time Based on Pseudo-Observations,” . Lifetime Data Analysis , 10 : 335 – 350 .
   PubMed Web of Science ®Google Scholar
• Bonetti , M. and Gelber , R. D. 2000 . “A Graphical Method to Assess Treatment-Covariate Interactions Using the Cox Model on Subsets of the Data,” . Statistics in Medicine , 19 : 2595 – 2609 .
   PubMed Web of Science ®Google Scholar
• Bonetti , M. and Gelber , R. D. 2005 . “Patterns of Treatment Effects in Subsets of Patients in Clinical Trials,” . Biostatistics , 5 : 465 – 481 .
   Web of Science ®Google Scholar
• Braunwald , E. , Domanski , M. J. , Fowler , S. E. , Geller , N. L. , Gersh , B. J. , Hsia , J. , Pfeffer , M. A. , Rice , M. M. , Rosenberg , Y. D. , Rouleau , J. L. and The PEACE Trial Investigators . 2004 . “Angiotensin-Converting-Enzyme Inhibition in Stable Coronary Artery Disease,” . The New England Journal of Medicine , 351 : 2058 – 2068 .
   PubMed Web of Science ®Google Scholar
• Breiman , L. 1996 . “Bagging Predictors,” . Machine Learning , 24 : 123 – 140 .
   Web of Science ®Google Scholar
• Cai , T. , Tian , L. , Wong , P. and Wei , L. 2011 . “Analysis of Randomized Comparative Clinical Trial Data for Personalized Treatment Selections,” . Biostatistics , 12 : 270
   PubMed Web of Science ®Google Scholar
• Cole , S. and Stuart , E. 2010 . “Generalizing Evidence From Randomized Clinical Trials to Target Populations,” . American Journal of Epidemiology , 172 : 107 – 115 .
   PubMed Web of Science ®Google Scholar
• Cox , D. R. 1972 . “Regression Models and Life-Tables” (with discussion), . Journal of the Royal Statistical Society, Series B , 34 : 187 – 220 .
   Web of Science ®Google Scholar
• Frangakis , C. 2009 . “The Calibration of Treatment Effects From Clinical Trials to Target Populations,” . Clinical Trials , 6 : 136 – 140 .
   PubMed Web of Science ®Google Scholar
• Hammer , S. , Squires , K. , Hughes , M. , Grimes , J. , Demeter , L. , Currier , J. , Eron , J. , Feinberg , J. , Balfour , H. , Deyton , L. , Chodakewitz , J. A. and Fischl , M. A. 1997 . “A Controlled Trial of Two Nucleoside Analogues Plus Indinavir in Persons With Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 Per Cubic Millimeter or Less,” . New England Journal of Medicine-Unbound , 337 : 725 – 733 .
   PubMed Web of Science ®Google Scholar
• Hoerl , A. and Kennard , R. 1970 . “Ridge Regression: Biased Estimation for Nonorthogonal Problems,” . Technometrics , 12 : 55 – 67 .
   Web of Science ®Google Scholar
• Irwin , J. 1949 . “The Standard Error of an Estimate of Expectation of Life, With Special Reference to Expectation of Tumourless Life in Experiments With Mice,” . Journal of Hygiene , 47 : 188 – 189 .
   PubMedGoogle Scholar
• Janes , H. , Pepe , M. , Bossuyt , P. and Barlow , W. 2011 . “Measuring the Performance of Markers for Guiding Treatment Decisions,” . Annals of Internal Medicine , 154 : 253 – 259 .
   PubMed Web of Science ®Google Scholar
• Kalbfleisch , J. D. and Prentice , R. L. 1981 . “Estimation of the Average Hazard Ratio,” . Biometrika , 68 : 105 – 112 .
   Web of Science ®Google Scholar
• Kalbfleisch , J. D. and Prentice , R. L. 2002 . The Statistical Analysis of Failure Time Data , New York : Wiley .
   Google Scholar
• Knight , K. and Fu , W. 2000 . “Asymptotics for Lasso-Type Estimators,” . The Annals of Statistics , 28 : 1356 – 1378 .
   Web of Science ®Google Scholar
• Lin , D. Y. and Wei , L. J. 1989 . “The Robust Inference for the Cox Proportional Hazards Model,” . Journal of American Statistical Association , 84 : 1074 – 1078 .
   Web of Science ®Google Scholar
• Moskowitz , C. and Pepe , M. 2004 . “Quantifying and Comparing the Predictive Accuracy of Continuous Prognostic Factors for Binary Outcomes,” . Biostatistics , 5 : 113
   PubMed Web of Science ®Google Scholar
• Pfeffer , M. and Jarcho , J. 2006 . “The Charisma of Subgroups and the Subgroups of CHARISMA,” . New England Journal of Medicine , 354 : 1744 – 1746 .
   PubMed Web of Science ®Google Scholar
• Rothwell , P. 2005 . “External Validity of Randomised Controlled Trials: ‘To Whom do the Results of This Trial Apply?’” . The Lancet , 365 : 82 – 93 .
   PubMed Web of Science ®Google Scholar
• Solomon , S. D. , Rice , M. M. , Jablonski , K. , Jose , P. , Domanski , M. , Sabatine , M. , Gersh , B. J. , Rouleau , J. , Pfeffer , M. A. , Braunwald , E. and Prevention of Events With ACE Inhibition (PEACE) Investigators . 2006 . “Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events With ACE inhibition (PEACE) Trial,” . Circulation , 114 : 26 – 31 .
   PubMed Web of Science ®Google Scholar
• Song , X. and Pepe , M. S. 2004 . “Evaluating Markers for Selecting a Patient's Treatment,” . Biometrics , 60 : 874 – 883 .
   PubMed Web of Science ®Google Scholar
• Song , X. and Zhou , X. 2011 . “Evaluating Markers for Treatment Selection Based on Survival Time,” . Working Paper No. 375, University of Washington Biostatistics
   Google Scholar
• Tibshirani , R. 1996 . “Regression Shrinkage and Selection via the Lasso,” . Journal of the Royal Statistical Society, Series B , 58 : 267 – 288 .
   Google Scholar
• Wang , R. , Lagakos , S. , Ware , J. , Hunter , D. and Drazen , J. 2007 . “Statistics in Medicine—Reporting of Subgroup Analyses in Clinical Trials,” . New England Journal of Medicine , 357 : 2189 – 2194 .
   PubMed Web of Science ®Google Scholar
• Xu , R. and O’Quigley , J. 2000 . “Estimating Average Regression Effect Under Non-Proportional Hazards,” . Biostatistics , 1 : 423 – 439 .
   PubMedGoogle Scholar